Novartis has welcomed a
recommendation by the Australian
Technical Advisory Group on
Immunisation that its Bexsero
meningitis B vaccine be used to
help protect young Australians,
with an emphasis on infants under
2 years of age and adolescents aged
between 15 and 19.
According to a statement issued
late yesterday inclusion of Bexsero
in the National Immunisation
Program is under consideration.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 14
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.